A cross-national comparison of public expenditures on drug treatment : context is key
Each year, around 1.2 million people in the European Union (EU) undergo treatment for problems related to drug abuse. There are associated requirements for policymakers and planners to determine the capacity and performance of national treatment systems and evaluate their costs. Responses are requir...
| Autor principal: | |
|---|---|
| Otros Autores: | |
| Tipo de documento: | Electrónico Libro |
| Lenguaje: | Inglés |
| Publicado: |
Luxembourg
Publications Office
2017
|
| En: | Año: 2017 |
| Acceso en línea: |
Volltext (kostenfrei) Volltext (kostenfrei) |
| Verificar disponibilidad: | HBZ Gateway |
| Palabras clave: |
MARC
| LEADER | 00000cam a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1866615777 | ||
| 003 | DE-627 | ||
| 005 | 20250115054921.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231020s2017 xx |||||o 00| ||eng c | ||
| 020 | |a 9789294972132 |9 978-92-9497-213-2 | ||
| 024 | 7 | |a 10.2810/812985 |2 doi | |
| 035 | |a (DE-627)1866615777 | ||
| 035 | |a (DE-599)KXP1866615777 | ||
| 035 | |a (OCoLC)1459221944 | ||
| 035 | |a (EUP)vtls000399661 | ||
| 035 | |a (DE-627-1)108201627 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 2,1 |2 ssgn | ||
| 100 | 1 | |a Lievens, Delfine |e VerfasserIn |4 aut | |
| 245 | 1 | 2 | |a A cross-national comparison of public expenditures on drug treatment : context is key |
| 264 | 1 | |a Luxembourg |b Publications Office |c 2017 | |
| 300 | |a 1 Online-Ressource (191 p.) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access | |
| 520 | |a Each year, around 1.2 million people in the European Union (EU) undergo treatment for problems related to drug abuse. There are associated requirements for policymakers and planners to determine the capacity and performance of national treatment systems and evaluate their costs. Responses are required to central policy questions such as 'What treatments are offered?', 'Are they effective?' and 'How much does treatment cost?'. However, despite the collection of data on treatment activity being relatively well established in Europe, there has been limited focus on the costs of, and expenditure on, drug treatment. Limited data and/or insufficient insight into the financing of drug treatment will inevitably hinder the efficient allocation of resources. This European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Insights report gathers together studies from a wide range of experts, providing a unique overview of the methodologies currently used for estimating drug treatment expenditure. In the absence of a systematic discussion of these issues, there has been little opportunity for policymakers, practitioners and researchers to take advantage of existing knowledge and experience. With the goal of taking the first step towards closing this gap, this report brings together a set of diverse studies encompassing much of the recent work on drug treatment expenditure in different parts of the world. It therefore reflects the current state of the art in this field and, by focusing on methods, it will facilitate analysis of the main methodological commonalities and considerations arising from these estimates. | ||
| 540 | |a Reproduction is authorised provided the source is acknowledged | ||
| 650 | 4 | |a Drug addiction | |
| 650 | 4 | |a social problem | |
| 650 | 4 | |a therapeutics | |
| 650 | 4 | |a health expenditure | |
| 650 | 4 | |a public expenditure | |
| 650 | 4 | |a EU Member State | |
| 700 | 1 | |a Vander Laenen, Freya |e VerfasserIn |4 aut | |
| 856 | 4 | 0 | |u https://core.ac.uk/download/154407594.pdf |x Verlag |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.2810/812985 |m X:EUP |x Resolving-System |z kostenfrei |3 Volltext |
| 912 | |a ZDB-330-EUO | ||
| 935 | |a mkri | ||
| 951 | |a BO | ||
| ELC | |a 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 4394252369 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1866615777 | ||
| LOK | |0 005 20231020043720 | ||
| LOK | |0 008 231020||||||||||||||||ger||||||| | ||
| LOK | |0 035 |a (DE-2619)CORE50536722 | ||
| LOK | |0 040 |a DE-2619 |c DE-627 |d DE-2619 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-2619 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 935 |a core | ||
| OAS | |a 1 | ||
| ORI | |a SA-MARC-krimdoka001.raw | ||